BCTX 241115 7.50C (BCTX241115C7500) Stock Options, News & Quotes

0.05
0.000.00%

15min DelayTrading Oct 8 14:08 ET

0.00High0.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Trytosaveabit

Oct 22 06:56

Update

$BriaCell Therapeutics (BCTX.US)$ BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
3 MINUTES AGO, 7:50 AM EDT
VIA GLOBENEWSWIRE
55% of BriaCell patients1 remained alive one year since enrollment in BriaCell's Phase 2 study, markedly exceeding the survival rate of current standard of care for similar patients
Multiple outperforming patients with overall survival of over 2 years
Survival benefit observed even in heavily pre-treated patients w...

Jaguar8

Oct 22 06:51

NEWS

$BriaCell Therapeutics (BCTX.US)$
BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
▪️55% of BriaCell patients1 remained alive one year since enrollment in BriaCell's Phase 2 study, markedly exceeding the survival rate of current standard of care for similar patients
▪️Multiple outperforming patients with overall survival of over 2 years
▪️Survival benefit observed even in heavily pre-treated patients who failed treatment with checkpoint inhib...

Willy 5150

Oct 17 20:14

Today's Price Action 0.79 - 0.85

$BriaCell Therapeutics (BCTX.US)$ This is the area of interest for me, and today's candle was green, but I still need to see more PA, and see if this is going to give me any bullish patterns. Might start scaling back into this again imo.

Trytosaveabit

Oct 15 06:56

Update

$BriaCell Therapeutics (BCTX.US)$ BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
5 MINUTES AGO, 7:50 AM EDT
VIA GLOBENEWSWIRE
35 sites active and enrolling in pivotal Phase 3 study of Bria-IMT™ combination with immune check point inhibitor in metastatic breast cancer (MBC)
Primary endpoint is overall survival (OS) with Bria-IMT™ regimen plus Check Point Inhibitor (CPI) vs treatment of physician's choice
Interim data analysis planned at 144 eve...

Willy 5150

Oct 14 17:56

0.79 - 0.85 Area On Watch.

$BriaCell Therapeutics (BCTX.US)$ If that holds, and shows bullish candle patterns, I'll start scaling in.... just for a low risk swing to the upside imo.